U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H26N2O4S
Molecular Weight 366.475
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GLIBORNURIDE

SMILES

CC1=CC=C(C=C1)S(=O)(=O)NC(=O)N[C@@H]2[C@H](O)[C@]3(C)CC[C@H]2C3(C)C

InChI

InChIKey=RMTYNAPTNBJHQI-LLDVTBCESA-N
InChI=1S/C18H26N2O4S/c1-11-5-7-12(8-6-11)25(23,24)20-16(22)19-14-13-9-10-18(4,15(14)21)17(13,2)3/h5-8,13-15,21H,9-10H2,1-4H3,(H2,19,20,22)/t13-,14+,15+,18+/m1/s1

HIDE SMILES / InChI

Molecular Formula C18H26N2O4S
Molecular Weight 366.475
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Description

Glibornuride is sulphonylurea derivative used as an oral hypoglycemic drug in patients with diabetes. The drug was marketed under the name Glutril, however, it is no longer available.

Originator

Approval Year

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
GLUTRIL

PubMed

Patents

Sample Use Guides

In Vivo Use Guide
The recommended dose is 0.5 tablet (1 tablet contains 25 mg of glibornuride) per day, given at breakfast time. Do not take more than 3 tablets per day.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Record UNII
VP83E7434R
Record Status Validated (UNII)
Record Version